Ionis Pharmaceuticals, Inc. United States of America (USA)
Research
Date range: 1 January 2022 - 31 December 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Ionis Pharmaceuticals, Inc. published between 1 January 2022 - 31 December 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
8 | 1.77 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Chemistry | 2 | 0.49 |
Life Sciences | 7 | 1.36 |
Share output for the past 5 years
2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
4.08 | 2.79 | 4.60 | 5.65 | 1.77 |
Nature Strategy Reports
Nature Strategy Reports gives you simple insights to support decisions that impact your organisation
The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.
Collaboration
Date range: 1 January 2022 - 31 December 2022
International vs. domestic collaboration by Share
- 64.27% Domestic
- 35.73% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Ionis Pharmaceuticals, Inc. by Share (16 total)
-
Ionis Pharmaceuticals, Inc. and Columbia University in the City of New York (CU)
(1.00)
-
Ionis Pharmaceuticals, Inc. and Cystic Fibrosis Foundation (CFF)
(1.00)
-
Ionis Pharmaceuticals, Inc. and National Institutes of Health (NIH)
(0.99)
-
Ionis Pharmaceuticals, Inc. and The University of Texas MD Anderson Cancer Center
(0.87)
-
Ionis Pharmaceuticals, Inc. and The University of Utah (Utah)
(0.77)
-
Ionis Pharmaceuticals, Inc. and Northwestern University (NU)
(0.71)
-
Ionis Pharmaceuticals, Inc. and Rosalind Franklin University of Medicine and Science (RFUMS)
(0.24)
-
Ionis Pharmaceuticals, Inc. and Scripps Research
(0.24)
-
Ionis Pharmaceuticals, Inc. and Louisiana State University (LSU)
(0.14)
-
Ionis Pharmaceuticals, Inc. and The University of Texas at Austin (UT Austin)
(0.14)
Top 10 international collaborators with Ionis Pharmaceuticals, Inc. by Share (18 total)
-
Ionis Pharmaceuticals, Inc. and University of Montreal (UdeM)
(0.83)
-
Ionis Pharmaceuticals, Inc. and University of the Basque Country (UPV/EHU)
(0.45)
-
Ionis Pharmaceuticals, Inc. and University of Alberta (U of A)
(0.29)
-
Ionis Pharmaceuticals, Inc. and Institute of Health Carlos III (ISCIII)
(0.28)
-
Ionis Pharmaceuticals, Inc. and University of Bologna (UNIBO)
(0.19)
-
Ionis Pharmaceuticals, Inc. and Ludwig Maximilians University of Munich (LMU)
(0.18)
-
Ionis Pharmaceuticals, Inc. and University of Oviedo (UniOvi)
(0.18)
-
Ionis Pharmaceuticals, Inc. and University of Santiago de Compostela (USC)
(0.16)
-
Ionis Pharmaceuticals, Inc. and Basque Research and Technology Alliance (BRTA)
(0.14)
-
Ionis Pharmaceuticals, Inc. and Center for Cooperative Research in Biosciences (CIC bioGUNE)
(0.14)

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.